Search Results - "Dompe, Nicholas"
-
1
A CRISPR screen identifies MAPK7 as a target for combination with MEK inhibition in KRAS mutant NSCLC
Published in PloS one (18-06-2018)“…Mutant KRAS represents one of the most frequently observed oncogenes in NSCLC, yet no therapies are approved for tumors that express activated KRAS variants…”
Get full text
Journal Article -
2
A complementary transposon tool kit for Drosophila melanogaster using P and piggyBac
Published in Nature genetics (01-03-2004)“…With the availability of complete genome sequence for Drosophila melanogaster, one of the next strategic goals for fly researchers is a complete gene knockout…”
Get full text
Journal Article -
3
Systematic generation of high-resolution deletion coverage of the Drosophila melanogaster genome
Published in Nature genetics (01-03-2004)“…In fruit fly research, chromosomal deletions are indispensable tools for mapping mutations, characterizing alleles and identifying interacting loci. Most…”
Get full text
Journal Article -
4
whole-genome RNAi screen identifies an 8q22 gene cluster that inhibits death receptor-mediated apoptosis
Published in Proceedings of the National Academy of Sciences - PNAS (25-10-2011)“…Deregulation of apoptosis is a common occurrence in cancer, for which emerging oncology therapeutic agents designed to engage this pathway are undergoing…”
Get full text
Journal Article -
5
Abstract 4410: Predictive model of palbociclib response reveals indications in which CDK4/6 inhibitor can be a potential combination partner
Published in Cancer research (Chicago, Ill.) (01-07-2019)“…CDK4/6 inhibitors are a promising class of targeted therapies, with three molecules (palbociclib, ribociclib, and abemaciclib) approved for advanced…”
Get full text
Journal Article -
6
Design of a brain-penetrant CDK4/6 inhibitor for glioblastoma
Published in Bioorganic & medicinal chemistry letters (15-08-2019)“…[Display omitted] CDK4 and CDK6 are kinases with similar sequences that regulate cell cycle progression and are validated targets in the treatment of cancer…”
Get full text
Journal Article -
7
Abstract B22: Potential combinatorial strategies to overcome drug resistance in BRAF-mutant melanoma
Published in Clinical cancer research (15-02-2015)“…RAF and MEK inhibitors are used to target malignant melanomas harbouring BRAF V600E mutations, but resistance to these therapies remains a significant…”
Get full text
Journal Article -
8
A whole-genome RNAi screen identifies an 8q22 gene cluster that inhibits death receptor-mediated apoptosis
Published in Proceedings of the National Academy of Sciences - PNAS (25-10-2011)Get full text
Journal Article -
9
Amphiregulin and PTEN evoke a multimodal mechanism of acquired resistance to PI3K inhibition
Published in Genes & cancer (01-03-2014)“…Phosphoinositide-3 kinase (PI3K) signaling pathway alterations occur broadly in cancer and PI3K is a promising therapeutic target. Here, we investigated…”
Get full text
Journal Article